|Persistent hypogammaglobulinemia without infection| | | |
|In the setting of persistent hypogammaglobulinemia without infection, continuation of rituximab therapy for patients at target is conditionally recommended over switching to a different bDMARD or tsDMARD.|Very low|PICO 66|p. 429|
|Previous serious infection| | | |